Intranasal COVID vaccine: Bharat Biotech to launch iNCOVACC on January 26

INCOVACC is a nasal vaccine indicated for active immunization against SARS-CoV-2 virus infection.

Published On 2023-01-23 05:45 GMT   |   Update On 2024-02-13 20:14 GMT
Advertisement

Bhopal: Bharat Biotech will launch its intranasal Covid-19 vaccine iNCOVACC on January 26, the company's CMD Krishna Ella announced. 

The vaccine manufacturer had already received approval from the Central Drugs Standard Control Organisation (CDSCO) earlier this month for the nasal vaccine, the first of its kind in India.

INCOVACC is a nasal vaccine indicated for active immunization against SARS-CoV-2 virus infection.

Advertisement

"Our nasal vaccine will be officially launched on Republic Day on January 26," said Ella while participating in a session during the 8th edition of the India International Science Festival (IISF) that began at the Maulana Azad National Institute of Technology (MANIT), here on Saturday.

Read also: Bharat Biotech partner Ocugen announces positive top-line data for COVID vaccine Covaxin

The session was titled 'Face-to-Face with New Frontiers in Science'.

The company had earlier announced that it would price the intranasal vaccine at Rs 325 per shot for procurement by the government, and 800 per shot for private vaccination centres.

Read also: COVID intranasal vaccine: Bharat Biotech iNCOVACC priced at Rs 800 for private hospitals, Rs 325 for Govt

As per the vaccine manufacturer, the nasal route has excellent potential for vaccination due to the organised immune system of the nasal mucosa. Thus, intranasal immunisation of ChAd-SARS-CoV-2-S can create an immune response in the nose, which is the point of entry for the virus, thereby protecting against disease, infection, and transmission.

The nasal vaccine can be taken after six months of the second dose.

An intranasal vaccine stimulates a broad immune response – neutralizing IgG, mucosal IgA, and T cell responses.

COVID-19 disease iscaused by a Coronavirus called SARS-CoV-2. You can get COVID-19 through contact with another person who has the virus. It is predominantly a respiratory illness that can affect other organs. People with COVID-19 may experience wide range of symptoms from mild to severe category. Symptoms may appear 2 to 14 days after exposure to the virus. Symptoms may include fever or chills; cough; shortness of breath; fatigue; muscle or body aches; headache; loss of taste or smell of recent onset; sore throat; congestion or runny nose; nausea or vomiting; diarrhea.

Read also: Bharat Biotech founder Dr Krishna Ella bats for incentives, tax breaks for patented products, innovation

Tags:    
Article Source : with inputs

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News